POGZ DEFICIENCY LEADS TO ABNORMAL BEHAVIOR, TRANSCRIPTION DYSREGULATION AND IMPAIRED CEREBELLAR PHYSIOLOGY

Reut Suliman; Ben Title; Yahel Cohen; Maayan Tal; Nitzan Tal; Bjorg Gudmundsdottir; Kristbjorn Gudmundsson; Jonathan Keller; Guo-Jen Huang; Yosef Yarom; Sagiv Shifman

doi:10.1016/j.euroneuro.2019.07.223

POGZ DEFICIENCY LEADS TO ABNORMAL BEHAVIOR, TRANSCRIPTION DYSREGULATION AND IMPAIRED CEREBELLAR PHYSIOLOGY

Reut Suliman, Ben Title, Yahel Cohen, Maayan Tal, Nitzan Tal, Bjorg Gudmundsdottir, Kristbjorn Gudmundsson, Jonathan Keller, Guo-Jen Huang, Yosef Yarom, Sagiv Shifman

Department of Biomedical Sciences (Master's Program in Clinical Trials Assessment)

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	European Neuropsychopharmacology
Volume	29
DOIs	https://doi.org/10.1016/j.euroneuro.2019.07.223
State	Published - 2019

Access to Document

10.1016/j.euroneuro.2019.07.223

Cite this

@article{a98bd4cd1cec45be8d659b2af4c205f5,

title = "POGZ DEFICIENCY LEADS TO ABNORMAL BEHAVIOR, TRANSCRIPTION DYSREGULATION AND IMPAIRED CEREBELLAR PHYSIOLOGY",

author = "Reut Suliman and Ben Title and Yahel Cohen and Maayan Tal and Nitzan Tal and Bjorg Gudmundsdottir and Kristbjorn Gudmundsson and Jonathan Keller and Guo-Jen Huang and Yosef Yarom and Sagiv Shifman",

year = "2019",

doi = "10.1016/j.euroneuro.2019.07.223",

language = "American English",

volume = "29",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - POGZ DEFICIENCY LEADS TO ABNORMAL BEHAVIOR, TRANSCRIPTION DYSREGULATION AND IMPAIRED CEREBELLAR PHYSIOLOGY

AU - Suliman, Reut

AU - Title, Ben

AU - Cohen, Yahel

AU - Tal, Maayan

AU - Tal, Nitzan

AU - Gudmundsdottir, Bjorg

AU - Gudmundsson, Kristbjorn

AU - Keller, Jonathan

AU - Huang, Guo-Jen

AU - Yarom, Yosef

AU - Shifman, Sagiv

PY - 2019

Y1 - 2019

U2 - 10.1016/j.euroneuro.2019.07.223

DO - 10.1016/j.euroneuro.2019.07.223

M3 - Journal Article

SN - 0924-977X

VL - 29

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -